Skip to main content
Log in

Sensitivity of selected members of the family Halobacteriaceae to quinolone antimicrobial compounds

  • Original paper
  • Published:
Archives of Microbiology Aims and scope Submit manuscript

Abstract

Many members of the Halobacteriaceae are inhibited by quinolone compounds, which inhibit type II DNA topoisomerase. Ciprofloxacin was the most potent inhibitor, followed by ofloxacin and norfloxacin. Ciprofloxacin concentrations between 25 and 60 μg/ml caused 50% inhibition of the growth of most Haloferax and Haloarcula species. Halobacterium species were less sensitive. At sublethal concentrations, formation of elongated and/or swollen cells was observed in many species. The alkaliphilic Natronobacterium pharaonis was very sensitive (50% inhibition by ciprofloxacin, ofloxacin, and norfloxacin at concentrations between 4 and 15 μg/ml). The resistance of many members of the Halobacteriaceae to high concentrations of quinolone compounds may in part be due to the high magnesium concentrations present in the growth media. Haloferax volcanii was sensitive to 40 μg/ml ciprofloxacin when grown at suboptimal magnesium concentrations (0.1 M), but was hardly affected by 100 μg/ml of the inhibitor when grown in the presence of 0.5–0.75 M MgCl2. It is suggested that the putative archaeal type II DNA topoisomerase has properties similar to those of the enzyme from Bacteria, although its sensitivity to quinolone antimicrobial compounds may be lower.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received: 6 November 1995 / Accepted: 26 February 1996

Rights and permissions

Reprints and permissions

About this article

Cite this article

Oren, A. Sensitivity of selected members of the family Halobacteriaceae to quinolone antimicrobial compounds. Arch Microbiol 165, 354–358 (1996). https://doi.org/10.1007/s002030050338

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s002030050338

Navigation